Baird Reiterates Outperform on Immutep, Maintains $7 Price Target
Portfolio Pulse from richadhand@benzinga.com
Baird analyst Joel Beatty has reiterated his 'Outperform' rating on Immutep (NASDAQ:IMMP) and maintained a $7 price target.
August 28, 2023 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Joel Beatty has reiterated his 'Outperform' rating on Immutep and maintained a $7 price target.
The reiteration of the 'Outperform' rating and maintenance of the $7 price target by Baird analyst Joel Beatty indicates a positive outlook for Immutep. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100